APRAMYCIN 200 mg/ml solution for injection 200 mg/ml България - български - БАБХ (Българска агенция по безопасност на храните)

apramycin 200 mg/ml solution for injection 200 mg/ml

Биовет АД - Апрамицину сулфат - инжекционен разтвор - 200 mg/ml - телета

APRAVET 100 g/kg premix for medicated feeding stuff for pigs 100 g/kg България - български - БАБХ (Българска агенция по безопасност на храните)

apravet 100 g/kg premix for medicated feeding stuff for pigs 100 g/kg

huvepharma nv - Апрамицину - премикс за медикаментозен фураж - 100 g/kg - свине

APRAMYCIN 500 mg/g WSP 500 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

apramycin 500 mg/g wsp 500 mg/g

Биовет АД - Апрамицину сулфат - прах за прилагане във вода за пиене/мляко - 500 mg/g - агнета, зайци, пилета, прасета, телета

Macropen 400 mg film - coated tablets България - български - Изпълнителна агенция по лекарствата

macropen 400 mg film - coated tablets

krka, d.d. novo mesto - midecamycin - 400 mg film - coated tablets

Macropen 175 mg/ 5 ml granules for oral suspension България - български - Изпълнителна агенция по лекарствата

macropen 175 mg/ 5 ml granules for oral suspension

krka, d.d. novo mesto - midecamycin - 175 mg/ 5 ml granules for oral suspension

APRAVET 552 IU/mg powder for use in drinking water/milk for pigs, calves, chickens and rabbits 552 IU/mg България - български - БАБХ (Българска агенция по безопасност на храните)

apravet 552 iu/mg powder for use in drinking water/milk for pigs, calves, chickens and rabbits 552 iu/mg

huvepharma nv - Апрамицину - Прах за прилагане във водата за пиене - 552 iu/mg - зайци, пилета, прасета, телета

Blenrep Европейски съюз - български - EMA (European Medicines Agency)

blenrep

glaxosmithkline (ireland) limited - belantamab mafodotin - Множествена миелома - Антинеопластични средства - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Tecvayli Европейски съюз - български - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - Множествена миелома - Антинеопластични средства - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Zolsketil pegylated liposomal Европейски съюз - български - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Carvykti Европейски съюз - български - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - Множествена миелома - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.